Immunoassay Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the immunoassay market looks promising with opportunities in hospitals, blood banks, clinical laboratories, pharmaceutical and biotech companies, and academic research centers. The global immunoassay market is expected to grow with a CAGR of 5%-7% from 2020 to 2025. The major drivers for this market are rising prevalence of chronic and infectious diseases, technological advancements in POC testing products, and growing patient awareness of POC testing.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global immunoassay market report, please download the report brochure.
In this market, reagents & kits is the largest product of immunoassay, whereas infectious disease is the largest application. Growth in various segments of the immunoassay market are given below:
The study includes trends and forecast for the global immunoassay market by product and service, technology, application, platform, specimen, end user, and region as follows:
By Product and Service [Value ($ Million) shipment analysis for 2014 – 2025]:
Reagents & KitsAnalyzersSoftware
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
ELISAFirst-generationSecond-generationThird-generationFourth-generation & AboveRapid TestsWestern BlottingELISPOTImmuno-PCROther Technologies
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Infectious DiseasesEndocrinologyOncologyBone & Mineral DisordersCardiologyHematology & Blood ScreeningAutoimmune DisordersToxicologyNeonatal ScreeningOther Applications
By Platform [Value ($ Million) shipment analysis for 2014 – 2025]:
Chemiluminescence Immunoassays (CLIAs)Fluorescence Immunoassays (FIAs)Colorimetric Immunoassays (CIs)Radioimmunoassays (RIAs)Other Platforms
By Specimen [Value ($ Million) shipment analysis for 2014 – 2025]:
BloodSalivaUrineOther Specimens
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
HospitalsBlood BanksClinical LaboratoriesPharmaceutical and Biotech CompaniesAcademic Research CentersOthers
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomSpainGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the WorldBrazil
Some of the immunoassay companies profiled in this report include Roche, Abbott Laboratories, Siemens, Danaher Corporation, Sysmex Corporation, BioM?rieux, Ortho Clinical Diagnostics, DiaSorin, QIAGEN, and Thermo Fisher Scientific.
Lucintel forecasts that reagents & kits will remain the largest product and service segment over the forecast period due to the requirement of repeat purchases of kits and reagents, increasing number of immunoassay tests, and rising incidence of chronic and infectious diseases.
Within this market, hospitals will remain the largest end user segment over the forecast period due to increase in prevalence of chronic diseases, such as cancer, infectious diseases, and autoimmune diseases.
North America will remain the largest region over the forecast period due to increasing incidence of chronic diseases and improved healthcare infrastructure in the region.
Features of the Global Immunoassay Market
Market Size Estimates: Global immunoassay market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global immunoassay market size by various segments, such as product and service, technology, application, platform, specimen, end user in terms of value.Regional Analysis: Global immunoassay market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product and service, technology, application, platform, specimen, end user, and region for the global immunoassay market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global immunoassay market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global immunoassay market by product & service (reagents & kits, analyzers, and software), technology (ELISA, first-generation, second-generation, third-generation, fourth-generation & above, rapid tests, western blotting, ELISPOT, immuno-PCR, and other technologies), application (infectious diseases, endocrinology, oncology,bone & mineral disorders, cardiology, hematology & blood screening, autoimmune disorders, toxicology, neonatal screening, and other applications), platform (chemiluminescence immunoassays (CLIAs), fluorescence immunoassays (FIAs), colorimetric immunoassays (CIs), radioimmunoassays (RIAs), and other platforms), specimen (blood, saliva, urine, and other specimens), end user (hospitals, blood banks, clinical laboratories, pharmaceutical and biotech companies, academic research centers, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global immunoassay market?
Q.5 What are the business risks and threats to the global immunoassay market?
Q.6 What are emerging trends in this immunoassay market and the reasons behind them?
Q.7 What are some changing demands of customers in this immunoassay market?
Q.8 What are the new developments in this immunoassay market? Which companies are leading these developments?
Q.9 Who are the major players in this immunoassay market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this immunoassay market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global immunoassay market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product & Service (Reagents & Kits, Analyzers, and Software), Technology (ELISA, First-Generation, Second-Generation, Third-Generation, Fourth-Generation & Above, Rapid Tests, Western Blotting, ELISPOT, Immuno-PCR, and Other Technologies), Platform (Chemiluminescence Immunoassays (CLIAs), Fluorescence Immunoassays (FIAs), Colorimetric Immunoassays (CIs), Radioimmunoassays (RIAs), and Other Platforms), Specimen (Blood, Saliva, Urine, and Other Specimens), Application (Infectious Diseases, Endocrinology, Oncology, Bone & Mineral Disorders, Cardiology, Hematology & Blood Screening, Autoimmune Disorders, Toxicology, Neonatal Screening, and Other Applications), and End User (Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical And Biotech Companies, Academic Research Centers, and Others)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kimgdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the immunoassay market looks promising with opportunities in hospitals, blood banks, clinical laboratories, pharmaceutical and biotech companies, and academic research centers. The global immunoassay market is expected to grow with a CAGR of 5%-7% from 2020 to 2025. The major drivers for this market are rising prevalence of chronic and infectious diseases, technological advancements in POC testing products, and growing patient awareness of POC testing.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global immunoassay market report, please download the report brochure.
In this market, reagents & kits is the largest product of immunoassay, whereas infectious disease is the largest application. Growth in various segments of the immunoassay market are given below:
The study includes trends and forecast for the global immunoassay market by product and service, technology, application, platform, specimen, end user, and region as follows:
By Product and Service [Value ($ Million) shipment analysis for 2014 – 2025]:
Reagents & KitsAnalyzersSoftware
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
ELISAFirst-generationSecond-generationThird-generationFourth-generation & AboveRapid TestsWestern BlottingELISPOTImmuno-PCROther Technologies
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Infectious DiseasesEndocrinologyOncologyBone & Mineral DisordersCardiologyHematology & Blood ScreeningAutoimmune DisordersToxicologyNeonatal ScreeningOther Applications
By Platform [Value ($ Million) shipment analysis for 2014 – 2025]:
Chemiluminescence Immunoassays (CLIAs)Fluorescence Immunoassays (FIAs)Colorimetric Immunoassays (CIs)Radioimmunoassays (RIAs)Other Platforms
By Specimen [Value ($ Million) shipment analysis for 2014 – 2025]:
BloodSalivaUrineOther Specimens
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
HospitalsBlood BanksClinical LaboratoriesPharmaceutical and Biotech CompaniesAcademic Research CentersOthers
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North AmericaUnited StatesCanada MexicoEuropeUnited KingdomSpainGermanyFranceAsia PacificChinaIndiaJapanThe Rest of the WorldBrazil
Some of the immunoassay companies profiled in this report include Roche, Abbott Laboratories, Siemens, Danaher Corporation, Sysmex Corporation, BioM?rieux, Ortho Clinical Diagnostics, DiaSorin, QIAGEN, and Thermo Fisher Scientific.
Lucintel forecasts that reagents & kits will remain the largest product and service segment over the forecast period due to the requirement of repeat purchases of kits and reagents, increasing number of immunoassay tests, and rising incidence of chronic and infectious diseases.
Within this market, hospitals will remain the largest end user segment over the forecast period due to increase in prevalence of chronic diseases, such as cancer, infectious diseases, and autoimmune diseases.
North America will remain the largest region over the forecast period due to increasing incidence of chronic diseases and improved healthcare infrastructure in the region.
Features of the Global Immunoassay Market
Market Size Estimates: Global immunoassay market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global immunoassay market size by various segments, such as product and service, technology, application, platform, specimen, end user in terms of value.Regional Analysis: Global immunoassay market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different product and service, technology, application, platform, specimen, end user, and region for the global immunoassay market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global immunoassay market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global immunoassay market by product & service (reagents & kits, analyzers, and software), technology (ELISA, first-generation, second-generation, third-generation, fourth-generation & above, rapid tests, western blotting, ELISPOT, immuno-PCR, and other technologies), application (infectious diseases, endocrinology, oncology,bone & mineral disorders, cardiology, hematology & blood screening, autoimmune disorders, toxicology, neonatal screening, and other applications), platform (chemiluminescence immunoassays (CLIAs), fluorescence immunoassays (FIAs), colorimetric immunoassays (CIs), radioimmunoassays (RIAs), and other platforms), specimen (blood, saliva, urine, and other specimens), end user (hospitals, blood banks, clinical laboratories, pharmaceutical and biotech companies, academic research centers, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global immunoassay market?
Q.5 What are the business risks and threats to the global immunoassay market?
Q.6 What are emerging trends in this immunoassay market and the reasons behind them?
Q.7 What are some changing demands of customers in this immunoassay market?
Q.8 What are the new developments in this immunoassay market? Which companies are leading these developments?
Q.9 Who are the major players in this immunoassay market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this immunoassay market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global immunoassay market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product & Service (Reagents & Kits, Analyzers, and Software), Technology (ELISA, First-Generation, Second-Generation, Third-Generation, Fourth-Generation & Above, Rapid Tests, Western Blotting, ELISPOT, Immuno-PCR, and Other Technologies), Platform (Chemiluminescence Immunoassays (CLIAs), Fluorescence Immunoassays (FIAs), Colorimetric Immunoassays (CIs), Radioimmunoassays (RIAs), and Other Platforms), Specimen (Blood, Saliva, Urine, and Other Specimens), Application (Infectious Diseases, Endocrinology, Oncology, Bone & Mineral Disorders, Cardiology, Hematology & Blood Screening, Autoimmune Disorders, Toxicology, Neonatal Screening, and Other Applications), and End User (Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical And Biotech Companies, Academic Research Centers, and Others)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kimgdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Immunoassay Market Trends and Forecast
3.3: Global Immunoassay Market by Product and Service
3.3.1: Reagents & Kits
3.3.2: Analyzers
3.3.3: Software
3.4: Global Immunoassay Market by Technology
3.4.1: ELISA
3.4.2: First-generation
3.4.3: Second-generation
3.4.4: Third-generation
3.4.5: Fourth-generation & Above
3.4.6: Rapid Tests
3.4.7: Western Blotting
3.4.8: ELISPOT
3.4.9: Immuno-PCR
3.4.10: Other Technologies
3.5: Global Immunoassay Market by Application
3.5.1: Infectious Diseases
3.5.2: Endocrinology
3.5.3: Oncology
3.5.4: Bone & Mineral Disorders
3.5.5: Cardiology
3.5.6: Hematology & Blood Screening
3.5.7: Autoimmune Disorders
3.5.8: Toxicology
3.5.9: Neonatal Screening
3.5.10: Other Applications
3.6: Global Immunoassay Market by Platform
3.6.1: Chemiluminescence Immunoassays (CLIAs)
3.6.2: Fluorescence Immunoassays (FIAs)
3.6.3: Colorimetric Immunoassays (CIs)
3.6.4: Radioimmunoassays (RIAs)
3.6.5: Other Platforms
3.7: Global Immunoassay Market by Specimen
3.7.1: Blood
3.7.2: Saliva
3.7.3: Urine
3.7.4: Other Specimens
3.8: Global Immunoassay Market by End User
3.8.1: Hospitals
3.8.2: Blood Banks
3.8.3: Clinical Laboratories
3.8.4: Pharmaceutical and Biotech Companies
3.8.5: Academic Research Centers
3.8.6: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Immunoassay Market by Region
4.2: North American Immunoassay Market
4.2.1: Market by Product & Service: Reagents & Kits, Analyzers, and Software
4.2.2: Market by Technology: ELISA, First-Generation, Second-Generation, Third-Generation, Fourth-Generation & Above, Rapid Tests, Western Blotting, ELISPOT, Immuno-PCR, and Other Technologies
4.2.3: Market by Application: Infectious Diseases, Endocrinology, Oncology, Bone & Mineral Disorders, Cardiology, Hematology & Blood Screening, Autoimmune Disorders, Toxicology, Neonatal Screening, and Other Applications
4.2.4: Market by Platform: Chemiluminescence Immunoassays (CLIAs), Fluorescence Immunoassays (FIAs), Colorimetric Immunoassays (CIs), Radioimmunoassays (RIAs), and Other Platforms
4.2.5: Market by Specimen: Blood, Saliva, Urine, and Other Specimens
4.2.6: Market by End User: Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical And Biotech Companies, Academic Research Centers, and Others
4.2.7: The United States Immunoassay Market
4.2.8: The Canadian Immunoassay Market
4.2.9: The Mexican Immunoassay Market
4.3: European Immunoassay Market
4.3.1: Market by Product & Service: Reagents & Kits, Analyzers, and Software
4.3.2: Market by Technology: ELISA, First-Generation, Second-Generation, Third-Generation, Fourth-Generation & Above, Rapid Tests, Western Blotting, ELISPOT, Immuno-PCR, and Other Technologies
4.3.3: Market by Application: Infectious Diseases, Endocrinology, Oncology, Bone & Mineral Disorders, Cardiology, Hematology & Blood Screening, Autoimmune Disorders, Toxicology, Neonatal Screening, and Other Applications
4.3.4: Market by Platform: Chemiluminescence Immunoassays (CLIAs), Fluorescence Immunoassays (FIAs), Colorimetric Immunoassays (CIs), Radioimmunoassays (RIAs), and Other Platforms
4.3.5: Market by Specimen: Blood, Saliva, Urine, and Other Specimens
4.3.6: Market by End User: Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical And Biotech Companies, Academic Research Centers, and Others
4.3.7: The United Kingdom Immunoassay Market
4.3.8: The Spanish Immunoassay Market
4.3.9: The German Immunoassay Market
4.3.10: The French Immunoassay Market
4.4: APAC Immunoassay Market
4.4.1: Market by Product & Service: Reagents & Kits, Analyzers, and Software
4.4.2: Market by Technology: ELISA, First-Generation, Second-Generation, Third-Generation, Fourth-Generation & Above, Rapid Tests, Western Blotting, ELISPOT, Immuno-PCR, and Other Technologies
4.4.3: Market by Application: Infectious Diseases, Endocrinology, Oncology, Bone & Mineral Disorders, Cardiology, Hematology & Blood Screening, Autoimmune Disorders, Toxicology, Neonatal Screening, and Other Applications
4.4.4: Market by Platform: Chemiluminescence Immunoassays (CLIAs), Fluorescence Immunoassays (FIAs), Colorimetric Immunoassays (CIs), Radioimmunoassays (RIAs), and Other Platforms
4.4.5: Market by Specimen: Blood, Saliva, Urine, and Other Specimens
4.4.6: Market by End User: Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical And Biotech Companies, Academic Research Centers, and Others
4.4.7: The Chinese Immunoassay Market
4.4.8: The Indian Immunoassay Market
4.4.9: The Japanese Immunoassay Market
4.5: ROW Immunoassay Market
4.5.1: Market by Product & Service: Reagents & Kits, Analyzers, and Software
4.5.2: Market by Technology: ELISA, First-Generation, Second-Generation, Third-Generation, Fourth-Generation & Above, Rapid Tests, Western Blotting, ELISPOT, Immuno-PCR, and Other Technologies
4.5.3: Market by Application: Infectious Diseases, Endocrinology, Oncology, Bone & Mineral Disorders, Cardiology, Hematology & Blood Screening, Autoimmune Disorders, Toxicology, Neonatal Screening, and Other Applications
4.5.4: Market by Platform: Chemiluminescence Immunoassays (CLIAs), Fluorescence Immunoassays (FIAs), Colorimetric Immunoassays (CIs), Radioimmunoassays (RIAs), and Other Platforms
4.5.5: Market by Specimen: Blood, Saliva, Urine, and Other Specimens
4.5.6: Market by End User: Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical And Biotech Companies, Academic Research Centers, and Others
4.5.7: Brazilian Immunoassay Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Immunoassay Market by Product and Service
7.1.2: Growth Opportunities for the Global Immunoassay Market by Technology
7.1.3: Growth Opportunities for the Global Immunoassay Market by Application
7.1.4: Growth Opportunities for the Global Immunoassay Market by Platform
7.1.5: Growth Opportunities for the Global Immunoassay Market by Specimen
7.1.6: Growth Opportunities for the Global Immunoassay Market by End User
7.1.7: Growth Opportunities for the Global Immunoassay Market by Region
7.2: Emerging Trends in the Global Immunoassay Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Immunoassay Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Immunoassay Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Roche
8.2: Abbott Laboratories
8.3: Siemens
8.4: Danaher Corporation
8.5: Sysmex Corporation
8.6: BioM?rieux
8.7: Orth Clinical Diagnostics
8.8: DiaSorin
8.9: QIAGEN
8.10: Therm Fisher Scientific
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Immunoassay Market Trends and Forecast
3.3: Global Immunoassay Market by Product and Service
3.3.1: Reagents & Kits
3.3.2: Analyzers
3.3.3: Software
3.4: Global Immunoassay Market by Technology
3.4.1: ELISA
3.4.2: First-generation
3.4.3: Second-generation
3.4.4: Third-generation
3.4.5: Fourth-generation & Above
3.4.6: Rapid Tests
3.4.7: Western Blotting
3.4.8: ELISPOT
3.4.9: Immuno-PCR
3.4.10: Other Technologies
3.5: Global Immunoassay Market by Application
3.5.1: Infectious Diseases
3.5.2: Endocrinology
3.5.3: Oncology
3.5.4: Bone & Mineral Disorders
3.5.5: Cardiology
3.5.6: Hematology & Blood Screening
3.5.7: Autoimmune Disorders
3.5.8: Toxicology
3.5.9: Neonatal Screening
3.5.10: Other Applications
3.6: Global Immunoassay Market by Platform
3.6.1: Chemiluminescence Immunoassays (CLIAs)
3.6.2: Fluorescence Immunoassays (FIAs)
3.6.3: Colorimetric Immunoassays (CIs)
3.6.4: Radioimmunoassays (RIAs)
3.6.5: Other Platforms
3.7: Global Immunoassay Market by Specimen
3.7.1: Blood
3.7.2: Saliva
3.7.3: Urine
3.7.4: Other Specimens
3.8: Global Immunoassay Market by End User
3.8.1: Hospitals
3.8.2: Blood Banks
3.8.3: Clinical Laboratories
3.8.4: Pharmaceutical and Biotech Companies
3.8.5: Academic Research Centers
3.8.6: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Immunoassay Market by Region
4.2: North American Immunoassay Market
4.2.1: Market by Product & Service: Reagents & Kits, Analyzers, and Software
4.2.2: Market by Technology: ELISA, First-Generation, Second-Generation, Third-Generation, Fourth-Generation & Above, Rapid Tests, Western Blotting, ELISPOT, Immuno-PCR, and Other Technologies
4.2.3: Market by Application: Infectious Diseases, Endocrinology, Oncology, Bone & Mineral Disorders, Cardiology, Hematology & Blood Screening, Autoimmune Disorders, Toxicology, Neonatal Screening, and Other Applications
4.2.4: Market by Platform: Chemiluminescence Immunoassays (CLIAs), Fluorescence Immunoassays (FIAs), Colorimetric Immunoassays (CIs), Radioimmunoassays (RIAs), and Other Platforms
4.2.5: Market by Specimen: Blood, Saliva, Urine, and Other Specimens
4.2.6: Market by End User: Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical And Biotech Companies, Academic Research Centers, and Others
4.2.7: The United States Immunoassay Market
4.2.8: The Canadian Immunoassay Market
4.2.9: The Mexican Immunoassay Market
4.3: European Immunoassay Market
4.3.1: Market by Product & Service: Reagents & Kits, Analyzers, and Software
4.3.2: Market by Technology: ELISA, First-Generation, Second-Generation, Third-Generation, Fourth-Generation & Above, Rapid Tests, Western Blotting, ELISPOT, Immuno-PCR, and Other Technologies
4.3.3: Market by Application: Infectious Diseases, Endocrinology, Oncology, Bone & Mineral Disorders, Cardiology, Hematology & Blood Screening, Autoimmune Disorders, Toxicology, Neonatal Screening, and Other Applications
4.3.4: Market by Platform: Chemiluminescence Immunoassays (CLIAs), Fluorescence Immunoassays (FIAs), Colorimetric Immunoassays (CIs), Radioimmunoassays (RIAs), and Other Platforms
4.3.5: Market by Specimen: Blood, Saliva, Urine, and Other Specimens
4.3.6: Market by End User: Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical And Biotech Companies, Academic Research Centers, and Others
4.3.7: The United Kingdom Immunoassay Market
4.3.8: The Spanish Immunoassay Market
4.3.9: The German Immunoassay Market
4.3.10: The French Immunoassay Market
4.4: APAC Immunoassay Market
4.4.1: Market by Product & Service: Reagents & Kits, Analyzers, and Software
4.4.2: Market by Technology: ELISA, First-Generation, Second-Generation, Third-Generation, Fourth-Generation & Above, Rapid Tests, Western Blotting, ELISPOT, Immuno-PCR, and Other Technologies
4.4.3: Market by Application: Infectious Diseases, Endocrinology, Oncology, Bone & Mineral Disorders, Cardiology, Hematology & Blood Screening, Autoimmune Disorders, Toxicology, Neonatal Screening, and Other Applications
4.4.4: Market by Platform: Chemiluminescence Immunoassays (CLIAs), Fluorescence Immunoassays (FIAs), Colorimetric Immunoassays (CIs), Radioimmunoassays (RIAs), and Other Platforms
4.4.5: Market by Specimen: Blood, Saliva, Urine, and Other Specimens
4.4.6: Market by End User: Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical And Biotech Companies, Academic Research Centers, and Others
4.4.7: The Chinese Immunoassay Market
4.4.8: The Indian Immunoassay Market
4.4.9: The Japanese Immunoassay Market
4.5: ROW Immunoassay Market
4.5.1: Market by Product & Service: Reagents & Kits, Analyzers, and Software
4.5.2: Market by Technology: ELISA, First-Generation, Second-Generation, Third-Generation, Fourth-Generation & Above, Rapid Tests, Western Blotting, ELISPOT, Immuno-PCR, and Other Technologies
4.5.3: Market by Application: Infectious Diseases, Endocrinology, Oncology, Bone & Mineral Disorders, Cardiology, Hematology & Blood Screening, Autoimmune Disorders, Toxicology, Neonatal Screening, and Other Applications
4.5.4: Market by Platform: Chemiluminescence Immunoassays (CLIAs), Fluorescence Immunoassays (FIAs), Colorimetric Immunoassays (CIs), Radioimmunoassays (RIAs), and Other Platforms
4.5.5: Market by Specimen: Blood, Saliva, Urine, and Other Specimens
4.5.6: Market by End User: Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical And Biotech Companies, Academic Research Centers, and Others
4.5.7: Brazilian Immunoassay Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Immunoassay Market by Product and Service
7.1.2: Growth Opportunities for the Global Immunoassay Market by Technology
7.1.3: Growth Opportunities for the Global Immunoassay Market by Application
7.1.4: Growth Opportunities for the Global Immunoassay Market by Platform
7.1.5: Growth Opportunities for the Global Immunoassay Market by Specimen
7.1.6: Growth Opportunities for the Global Immunoassay Market by End User
7.1.7: Growth Opportunities for the Global Immunoassay Market by Region
7.2: Emerging Trends in the Global Immunoassay Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Immunoassay Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Immunoassay Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Roche
8.2: Abbott Laboratories
8.3: Siemens
8.4: Danaher Corporation
8.5: Sysmex Corporation
8.6: BioM?rieux
8.7: Orth Clinical Diagnostics
8.8: DiaSorin
8.9: QIAGEN
8.10: Therm Fisher Scientific
